Brain Tumor Meeting 2022

Donnerstag, 19. Mai — Freitag, 20. Mai 2022
Ort

MDC Berlin-Buch

Kurzinfo
 

 

Dear Colleague:

 

Due to Covid-19 pandemic the Brain Tumor Meeting 2021 has been postponed to 2022. We are hopeful that the pandemic situation will allow us to hold this meeting as a physical one and we are happy to announce the Brain Tumor Meeting 2022 which will take place at the Max Delbrück Center für Molecular Medicine (MDC) in Berlin (Germany) on May 19 – 20, 2022.

 

The deadline for early registration, abstract submission and stipend application is

 

February 21, 2022

 

Again, internationally renowned plenary speakers will present:

Gabriele Bergers (Leuven, Belgium)
„Metabolic traits of glioma invasion“

 

Giulio F. Draetta (Houston, USA)
„A novel potential therapeutic target in glioblastoma“

 

Rainer Glass (München, Germany)
„Converting NFKB into a tumor-suppressor“

 

Antonio Iavarone (New York, USA)
„Mechanisms of oncogenesis and precision medicine of glioblastoma“

 

Marcel Kool (Heidelberg, Germany)
„Pediatric brain tumors: how to translate all the molecular data into successful treatments for patients?“

 

Michelle Monje (Standford, USA)
„Glioma neuroscience: Neuron-glioma interactions drive glioma progression“

 

Itay Tirosh (Rehovot, Israel)
„Dissecting intra-tumor and inter-tumor heterogeneity in glioma“

 

Manuel Valiente (Madrid, Spain)
„Exploiting the translational potential of established and new brain metastasis models“

Furthermore, abstracts for oral and poster presentations are invited and the best presentations will be awarded prices.

In addition, stipends of up to 500 Euro will be available.

The meeting will take place at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin-Buch. It will start on Thursday, May 19, 2022, after lunch and will end in the afternoon of the next day on Friday, May 20, 2022. The registration fee is very low (€ 20 for students, € 60 for scientists) and includes coffee breaks.

 

In summer 2000 Berlin neuroscientists, neurosurgeons and neurologists focusing on brain tumors initiated this scientific conference. It was repeated since then biannually in the odd years and celebrates its 10th anniversary in 2022. Throughout this time the Brain Tumor Meeting gained national and international attention and attracted many leading scientists working on gliomas and other brain tumors.

 

The main focus of the meeting is to provide a platform for an interdisciplinary scientific exchange especially between scientists and clinicians. Recent discoveries on the role of glioma stem cells, on the interaction of gliomas with their microenvironment and on glioma cell death pathways have altered our understanding of glioma biology.

 

We would like to invite you to join this meeting. Please disseminate this information also to interested colleagues.

 

 Prof. Dr. Helmut Kettenmann
Cellular Neurosciences
Head of Department
Max-Delbrück Center for Molecular Medicine
Prof. Dr. med. Michael Synowitz
Department of Neurosurgery
Chairman
University Medical Center Schleswig-Holstein

 

Scientific Committee: Christoph Harms, Charité Campus Mitte;  Charlotte Flüh, UKSH, Kiel; Gaetano Gargiulo, MDC,  Helmut Kettenmann (Chair), MDC, Berlin-Buch; Michael Synowitz (Co-Chair), UKSH, Kiel
Conference Management: Meino Alexandra Gibson, Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Robert-Rössle-Str. 10, 13125 Berlin, Germany, Phone: +49 30 9406 3336, email: gibson@mdc-berlin.de
https://www.braintumor-berlin.de/

 

PDF-Download Infoflyer
Nach oben springen